Gene Therapy for Retinitis Pigmentosa Tested in Humans for the first time. French Biotech Horama has treated the first patients with a gene therapy for retinitis pigmentosa that could prevent the progressive loss of vision caused by this genetic condition A Phase 1/11 trial with Horama’s gene therapy for retinitis pigmentosa is running at the
